Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (58752) 58752
Newspaper Article (7312) 7312
Newsletter (2946) 2946
Magazine Article (533) 533
Book Chapter (477) 477
Trade Publication Article (128) 128
Web Resource (95) 95
Book / eBook (72) 72
Dissertation (54) 54
Transcript (41) 41
Publication (38) 38
Conference Proceeding (37) 37
Reference (22) 22
Government Document (15) 15
Streaming Video (11) 11
Book Review (8) 8
Journal / eJournal (2) 2
Paper (2) 2
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44106) 44106
anticoagulants (38819) 38819
science & technology (38321) 38321
life sciences & biomedicine (36608) 36608
male (21925) 21925
female (21492) 21492
anticoagulants - therapeutic use (19167) 19167
middle aged (14827) 14827
aged (13628) 13628
biological and medical sciences (13614) 13614
medical sciences (12935) 12935
cardiovascular system & cardiology (12056) 12056
adult (11129) 11129
anticoagulants - administration & dosage (9449) 9449
thrombosis (9122) 9122
hematology (9087) 9087
risk factors (8843) 8843
anticoagulants - adverse effects (8825) 8825
abridged index medicus (7334) 7334
peripheral vascular disease (7309) 7309
treatment outcome (7091) 7091
animals (6949) 6949
anticoagulants - pharmacology (6372) 6372
cardiac & cardiovascular systems (6249) 6249
stroke (6038) 6038
thromboembolism (5874) 5874
surgery (5685) 5685
pharmacology. drug treatments (5583) 5583
patients (5466) 5466
aged, 80 and over (5336) 5336
research (5285) 5285
heparin (5037) 5037
warfarin (4986) 4986
care and treatment (4959) 4959
analysis (4585) 4585
atrial fibrillation (4566) 4566
general & internal medicine (4519) 4519
retrospective studies (4348) 4348
drug therapy (4311) 4311
blood coagulation - drug effects (4219) 4219
time factors (4065) 4065
pharmacology & pharmacy (3946) 3946
blood. blood coagulation. reticuloendothelial system (3840) 3840
health aspects (3772) 3772
heparin - therapeutic use (3596) 3596
medicine, general & internal (3567) 3567
mortality (3549) 3549
administration, oral (3545) 3545
medicine & public health (3518) 3518
warfarin - therapeutic use (3457) 3457
cardiac arrhythmia (3443) 3443
hemorrhage - chemically induced (3259) 3259
prospective studies (3217) 3217
cardiology. vascular system (3211) 3211
medical research (3205) 3205
blood (3180) 3180
glycosaminoglycans (3161) 3161
thrombin (3119) 3119
blood clot (2973) 2973
anticoagulation (2940) 2940
blood clots (2932) 2932
cardiology (2891) 2891
heart (2871) 2871
adolescent (2771) 2771
hemorrhage (2673) 2673
prevention (2513) 2513
blood coagulation (2504) 2504
international normalized ratio (2471) 2471
heparin - administration & dosage (2434) 2434
medicine, experimental (2420) 2420
atrial fibrillation - drug therapy (2419) 2419
follow-up studies (2399) 2399
studies (2390) 2390
risk assessment (2388) 2388
warfarin - administration & dosage (2381) 2381
heparin - adverse effects (2372) 2372
bleeding (2370) 2370
clinical trials (2348) 2348
warfarin - adverse effects (2312) 2312
pregnancy (2304) 2304
medicine (2258) 2258
dose-response relationship, drug (2249) 2249
platelet aggregation inhibitors - therapeutic use (2185) 2185
proteins (2167) 2167
coagulation (2160) 2160
dosage and administration (2143) 2143
blood coagulation tests (2091) 2091
usage (2084) 2084
neurosciences & neurology (2082) 2082
blood and lymphatic vessels (2054) 2054
thromboembolism - prevention & control (2022) 2022
pulmonary embolism (2006) 2006
venous thromboembolism (1971) 1971
internal medicine (1937) 1937
cardiovascular disease (1926) 1926
complications and side effects (1925) 1925
aspirin (1923) 1923
stroke - prevention & control (1920) 1920
thrombosis - prevention & control (1915) 1915
drug dosages (1905) 1905
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (30) 30
Online Resources - Online (25) 25
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Scarborough Hospital - Online (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Mt Sinai Hospital - Online (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (66998) 66998
German (1253) 1253
French (829) 829
Russian (655) 655
Japanese (444) 444
Spanish (325) 325
Italian (289) 289
Chinese (212) 212
Portuguese (145) 145
Polish (106) 106
Dutch (79) 79
Czech (53) 53
Norwegian (42) 42
Hungarian (41) 41
Turkish (36) 36
Danish (34) 34
Swedish (29) 29
Ukrainian (27) 27
Romanian (23) 23
Korean (21) 21
Bulgarian (17) 17
Finnish (16) 16
Croatian (11) 11
Hebrew (11) 11
Serbian (6) 6
Icelandic (4) 4
Lithuanian (4) 4
Slovak (3) 3
Persian (2) 2
Bosnian (1) 1
Chamorro (1) 1
Greek (1) 1
Slovenian (1) 1
Urdu (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Blood coagulation & fibrinolysis
Lippincott-Raven Publishers
Blood coagulation & fibrinolysis, ISSN 0957-5235, 1990
Journal
Details down arrow
2. Quality in laboratory hemostasis and thrombosis
by Preston, F. E and Kitchen, Steve (Scientist) and Olson, John David, 1944
2009, 1, ISBN 9781405168038, xii, 215
Thrombophilia | Anticoagulants | Hemostasis | Hemostatic Techniques | Clinical Laboratory Techniques | Blood Coagulation Disorders, Inherited | Analysis | Blood Coagulation Factors | Diagnosis | Thrombosis | Blood coagulation disorders | Blood | Laboratory manuals
Book
Details down arrow
3. Full Text Hematological findings and complications of COVID‐19
by Terpos, Evangelos and Ntanasis‐Stathopoulos, Ioannis and Elalamy, Ismail and Kastritis, Efstathios and Sergentanis, Theodoros N and Politou, Marianna and Psaltopoulou, Theodora and Gerotziafas, Grigoris and Dimopoulos, Meletios A
American journal of hematology, ISSN 0361-8609, 07/2020, Volume 95, Issue 7, pp. 834 - 847
Life Sciences & Biomedicine | Hematology | Science & Technology | Meta-Analysis as Topic | Pandemics | COVID-19 Testing | Clinical Laboratory Techniques | Humans | Risk | Pneumonia, Viral - blood | Lymphopenia - etiology | Thrombophilia - etiology | Venous Thromboembolism - blood | COVID-19 | Venous Thromboembolism - prevention & control | SARS-CoV-2 | Blood Donors - supply & distribution | Ferritins - blood | Pneumonia, Viral - complications | Coronavirus Infections - blood | Betacoronavirus | Coronavirus Infections - complications | C-Reactive Protein - analysis | Thrombophilia - drug therapy | Cytokines - blood | Cytokine Release Syndrome - blood | Coronavirus Infections - diagnosis | Fibrin Fibrinogen Degradation Products - analysis | Anticoagulants - therapeutic use | Disseminated Intravascular Coagulation - blood | Venous Thromboembolism - etiology | Cytokine Release Syndrome - etiology | Thrombophilia - blood | Disseminated Intravascular Coagulation - etiology | Biomarkers | Blood Coagulation Tests | Pneumonia, Viral - diagnosis | Early Diagnosis | Thrombocytopenia | Vigilance | Degradation products | Blood & organ donations | Procalcitonin | Disseminated infection | Ferritin | Disseminated intravascular coagulation | Inflammation | Molecular weight | Hemopoiesis | Fibrin | Lymphopenia | Hemostasis | Cell number | Lymphocytes | Medical prognosis | Heparin | Thromboembolism | Index Medicus | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study
by Kim, Mimi Y., ScD and Buyon, Jill P., MD and Guerra, Marta M., MS and Rana, Sarosh, MD and Zhang, Dongsheng, PhD and Laskin, Carl A., MD and Petri, Michelle, MD, MPH and Lockshin, Michael D., MD and Sammaritano, Lisa R., MD and Branch, D. Ware, MD and Porter, T. Flint, MD, MPH and Merrill, Joan T., MD and Stephenson, Mary D., MD, MSc and Gao, Qi, PhD and Karumanchi, S. Ananth, MD and Salmon, Jane E., MD
American journal of obstetrics and gynecology, ISSN 0002-9378, 2016, Volume 214, Issue 1, pp. 108.e1 - 108.e14
Obstetrics and Gynecology | angiogenic factors | systemic lupus erythematosus | preeclampsia | placental insufficiency | antiphospholipid antibodies | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Predictive Value of Tests | Pregnancy Trimester, First - blood | Antibodies, Antiphospholipid - blood | Prospective Studies | Humans | Heparin - therapeutic use | Lupus Erythematosus, Systemic - blood | Young Adult | Endoglin | Pregnancy Proteins - blood | Pregnancy, High-Risk | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Aspirin - therapeutic use | Pregnancy Trimester, Second - blood | Antiphospholipid Syndrome - blood | Fetal Growth Retardation - blood | Severity of Illness Index | Antiphospholipid Syndrome - drug therapy | Anticoagulants - therapeutic use | Receptors, Cell Surface - blood | Biomarkers - blood | Gestational Age | Pregnancy | Antigens, CD - blood | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pre-Eclampsia - blood | Placenta Growth Factor | Vascular Endothelial Growth Factor Receptor-1 - blood | Pregnancy Outcome | Lupus | Prognosis | Systemic lupus erythematosus | Pregnant women | Growth | Patient outcomes | Analysis | Fetus | Antiphospholipid antibodies | Index Medicus | Abridged Index Medicus | Angiogenic factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Performance of coagulation tests in patients on therapeutic doses of rivaroxaban A cross-sectional pharmacodynamic study based on peak and trough plasma levels
by Francart, Suzanne J and Hawes, Emily M and Deal, Allison M and Adcock, Dorothy M and Gosselin, Robert and Jeanneret, Cheryl and Friedman, Kenneth D and Moll, Stephan
Thrombosis and haemostasis, ISSN 0340-6245, 06/2014, Volume 111, Issue 6, pp. 1133 - 1140
Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Biological and medical sciences | Blood coagulation. Blood cells | Molecular and cellular biology | Medical sciences | Platelet diseases and coagulopathies | Anticoagulants - administration & dosage | Humans | Middle Aged | Prothrombin Time | Male | Reference Values | Thiophenes - administration & dosage | Morpholines - blood | Thiophenes - blood | Venous Thromboembolism - drug therapy | Factor Xa Inhibitors - administration & dosage | Venous Thromboembolism - blood | Rivaroxaban | Factor Xa Inhibitors - blood | Blood Coagulation Tests - instrumentation | Adult | Blood Coagulation Tests - methods | Female | Factor Xa Inhibitors - pharmacology | Cross-Sectional Studies | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Factor Xa - metabolism | Anticoagulants - blood | Atrial Fibrillation - blood | Blood Coagulation - drug effects | Point-of-Care Systems | Partial Thromboplastin Time | Anticoagulants - pharmacology | Aged | Whole Blood Coagulation Time
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text A critical appraisal of point‐of‐care coagulation testing in critically ill patients
by Levi, M and Hunt, B. J
Journal of thrombosis and haemostasis, ISSN 1538-7933, 11/2015, Volume 13, Issue 11, pp. 1960 - 1967
critical care | thrombosis | point‐of‐care systems | platelet aggregation inhibitors | thoracic surgery | hemorrhage | Critical care | Point-of-care systems | Platelet aggregation inhibitors | Thoracic surgery | Hemorrhage | Thrombosis | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Critical Care - methods | Point-of-Care Systems - economics | Humans | Critical Illness | Critical Care - economics | Drug Monitoring - methods | Postoperative Hemorrhage - blood | Blood Loss, Surgical | Blood Transfusion | Wounds and Injuries - therapy | Blood Coagulation Tests - economics | Thrombelastography - economics | Hemorrhage - etiology | Platelet Function Tests | Blood Coagulation Tests - methods | Postoperative Hemorrhage - therapy | Hemorrhage - therapy | Wounds and Injuries - blood | Blood Coagulation Disorders - etiology | Wounds and Injuries - complications | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Anticoagulants - blood | Randomized Controlled Trials as Topic | Cost-Benefit Analysis | Blood Coagulation Disorders - blood | Blood Coagulation Disorders - diagnosis | Disease Management | Hemorrhage - chemically induced | Biological products | Medical examination | Health aspects | Blood | Acute coronary syndromes | Mortality | Coagulation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
by Y. C. Barrett and Z. Wang and C. Frost and A. Shenker
Thrombosis and haemostasis, ISSN 0340-6245, 12/2010, Volume 104, Issue 6, pp. 1263 - 1271
prothrombin time | anti-Xa activity | Factor Xa inhibitor | international normalised ratio | Apixaban | New Technologies, Diagnostic Tools and Drugs | Anti-Xa activity | International normalised ratio | Prothrombin time | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Biological and medical sciences | Blood coagulation. Blood cells | Molecular and cellular biology | Medical sciences | Platelet diseases and coagulopathies | Predictive Value of Tests | Pyrazoles - therapeutic use | Reproducibility of Results | Factor Xa Inhibitors | Humans | Prothrombin Time | Anticoagulants - therapeutic use | Drug Monitoring - methods | Morpholines - blood | Thiophenes - blood | Pyridones - blood | Venous Thromboembolism - drug therapy | Anticoagulants - blood | Venous Thromboembolism - blood | Dose-Response Relationship, Drug | International Normalized Ratio | Rivaroxaban | Blood Coagulation - drug effects | Pyrazoles - blood | Blood Coagulation Tests | Isoxazoles - blood | Pyridones - therapeutic use | Clinical Trials, Phase II as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome
by Blanchet, X and Cesarek, K and Brandt, J and Herwald, H and Teupser, D and Küchenhoff, H and Karshovska, E and Mause, S. F and Siess, W and Wasmuth, H and Soehnlein, O and Koenen, R. R and Weber, C and von Hundelshausen, P
Thrombosis and haemostasis, ISSN 0340-6245, 2014, Volume 112, Issue 6, pp. 1277 - 1287
Cardiovascular Biology and Cell Signalling | Acute coronary syndrome | Platelets | Chemokines | Atherosclerosis | Neutrophils | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Cardiology. Vascular system | Heart | Hematologic and hematopoietic diseases | Atherosclerosis (general aspects, experimental research) | Biological and medical sciences | Blood coagulation. Blood cells | Molecular and cellular biology | Medical sciences | Coronary heart disease | Blood and lymphatic vessels | Platelet diseases and coagulopathies | Predictive Value of Tests | Chemokines - blood | Blood Platelets - immunology | Prognosis | Prospective Studies | Humans | Middle Aged | Heparin - therapeutic use | Male | Case-Control Studies | Inflammation - blood | Chemokine CCL5 - blood | Dose-Response Relationship, Drug | Time Factors | Female | Inflammation - diagnosis | Antimicrobial Cationic Peptides - blood | Blood Platelets - drug effects | Neutrophils - metabolism | Carrier Proteins - blood | Neutrophils - drug effects | Inflammation Mediators - blood | Neutrophils - immunology | Acute Coronary Syndrome - immunology | Anticoagulants - therapeutic use | Linear Models | Inflammation - immunology | Biomarkers - blood | Chemokines - genetics | Disease Progression | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Platelet Count | Blood Platelets - metabolism | Blood Proteins | Acute Coronary Syndrome - diagnosis | Chemokine CCL5 - genetics | Aged | Polymorphism, Single Nucleotide | Acute Coronary Syndrome - genetics | Peroxidase - blood | atherosclerosis | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | chemokines | Klinisk medicin | neutrophils | platelets
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Consultative hemostasis and thrombosis
by Konkle, Barbara A and Kessler, Craig M and Kitchens, Craig S
08/2018, ISBN 0323462022, 1
Anticoagulants (Medicine) | Hemostasis | Blood platelet disorders | Thrombosis | Blood coagulation disorders | Fibrinolytic agents
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Coronavirus blood-clot mystery intensifies
by Willyard, Cassandra
Nature (London), ISSN 0028-0836, 05/2020, Volume 581, Issue 7808, pp. 250 - 250
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | COVID-19 | Fibrin Fibrinogen Degradation Products | Coronavirus Infections | Blood Coagulation Disorders - virology | SARS-CoV-2 | Coronavirus | Pandemics | Hospital Mortality | Humans | Betacoronavirus | Pneumonia, Viral | Prevention | Complications and side effects | Care and treatment | Patient outcomes | Anticoagulants (Medicine) | Dosage and administration | Diagnosis | Thrombosis | Blood clot | Coronaviruses | Blood vessels | Clinical trials | Infections | Health care facilities | t-Plasminogen activator | Blood | Endothelial cells | Blood clots | Severe acute respiratory syndrome coronavirus 2 | Proteins | Hospitals | Researchers | Dimers | Viral infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis
by Potze, Wilma and Arshad, Freeha and Adelmeijer, Jelle and Blokzijl, Hans and van den Berg, Arie P and Porte, Robert J and Lisman, Ton
British journal of haematology, ISSN 0007-1048, 12/2013, Volume 163, Issue 5, pp. 666 - 673
anti-Xa assay | PORTAL-VEIN THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | anticoagulants | antithrombin | CONSEQUENCES | LIVER-DISEASE | coagulation | HEMOSTASIS | cirrhosis | anti‐Xa assay | Anti-Xa assay | Anticoagulants | Cirrhosis | Antithrombin | Coagulation | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Biological and medical sciences | Medical sciences | Tumors | Thiophenes - therapeutic use | Heparin, Low-Molecular-Weight - pharmacology | Polysaccharides - blood | Factor Xa Inhibitors | beta-Alanine - blood | Humans | Middle Aged | Heparin - therapeutic use | Male | Dabigatran | Drug Monitoring - methods | Morpholines - blood | Heparin, Low-Molecular-Weight - therapeutic use | Thiophenes - blood | Thrombophilia - etiology | Antithrombins - pharmacology | Rivaroxaban | Heparin, Low-Molecular-Weight - blood | Sensitivity and Specificity | beta-Alanine - pharmacology | Prothrombin - antagonists & inhibitors | Female | beta-Alanine - analogs & derivatives | Benzimidazoles - blood | Heparin - pharmacology | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Polysaccharides - therapeutic use | Liver Cirrhosis - drug therapy | Liver Cirrhosis - complications | beta-Alanine - therapeutic use | False Negative Reactions | Morpholines - pharmacology | Thiophenes - pharmacology | Liver Cirrhosis - blood | Polysaccharides - pharmacology | Anticoagulants - blood | Diagnostic Tests, Routine | Blood Coagulation - drug effects | Thrombophilia - blood | Anticoagulants - pharmacology | Antithrombins - blood | Blood Coagulation Tests | Heparin - blood | Benzimidazoles - pharmacology | Liver cirrhosis | Anticoagulants (Medicine) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem
by Jaffer, Iqbal H and Weitz, Jeffrey I
Acta biomaterialia, ISSN 1742-7061, 08/2019, Volume 94, pp. 2 - 10
Medical devices | Anticoagulation | Thrombosis | Coagulation | Biomaterials | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Prevention | Transluminal angioplasty | Medical equipment | Biological products | Coronary artery bypass | Atherosclerosis | Thromboembolism | Physiological apparatus | Adenosine triphosphatase | Anticoagulants | Surgical implants | Complications | Risk reduction | Blood | Clotting | Bleeding | Biomedical materials | Reviews | Medical electronics | Biocompatibility | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights